ACCPLNSEACCRETION PHARMA LIMITEDMinimalNeutral
Announced Sat, 10 Oct, 2026 · 18:48 IST

All 5 postal ballot resolutions passed with full valid votes in favour

ACCPL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹188.95
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-0.3% vs market

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+0.6+0.8-0.3
Next day
+2.2+1.0+1.2
2d
—+1.7—
3d
—+0.1—
4d
—+0.8—
5d
—-0.9—
1w
+0.6-4.5+5.0
15d
———
1m
———
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Accretion Pharma shareholders approved all 5 special resolutions via postal ballot with all valid votes in favour and zero against. Items cover alteration of MoA, increase in borrowing limits under Section 180(1)(c), creation of charges on company assets, revised loan limits to subsidiaries under Section 185, and investment limits under Section 186. E-voting ran from September 10 to October 9, 2026.

Likely market impact

Higher borrowing and asset-backed charge approvals suggest possible expansion or fund raising plans ahead.